Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glucagon in Outpatient Colonoscopy
NCT02078726Phase 4Completed
- Sponsor
- University of California, San Francisco
- Start
- Apr 2014
- Primary completion
- May 2018
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in colon cancer comparing Glucagon with Placebo (2 arms). Primary endpoint: Adenoma Detection Rate. Started Apr 2014; status: completed.
02
Drugs
glucagon
03
Conditions
colon cancer
Beyond the preview
Go deeper on NCT02078726.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02078726.